BridgeMD
New treatment option for Insulin Resistance Syndrome
Official title Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause
ClinicalTrials.gov ID: NCT06806345
What this study is testing
What is Hypoglycemic Drug?
Hypoglycemic Drug is an investigational medicine, being studied as a potential treatment for insulin resistance syndrome.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Background: In postmenopausal females, Insulin resistance is commonly encountered in clinical setting. Hyperbaric oxygen therapy have been proposed effective in lowering blood glucose level and improving function.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 to 65, women only
You may be able to join if
- A) All females were clinically diagnosed with Postmenopausal Insulin resistance.
- Their ages were ranged from 55-65 years old.
- Their BMI was 30-34.9 kg/m².
- All patients should had controlled blood glucose levels by oral hypoglycemic drugs.
- All patients should had cardiac Ejection Fraction \>or =50%.
You likely can't join if
- Participants will be excluded if they have :
- Chronic obstructive pulmonary disease.
- Cardiac pacemakers.
- Epileptic fits.
- Physically disable .
- Any disorder that lead to ulcers other than diabetes such as ahistory of chronic peripheral arterial disease. Exclusion Criteria: \-
See the full eligibility criteria
- A) All females were clinically diagnosed with Postmenopausal Insulin resistance.
- Their ages were ranged from 55-65 years old.
- Their BMI was 30-34.9 kg/m².
- All patients should had controlled blood glucose levels by oral hypoglycemic drugs.
- All patients should had cardiac Ejection Fraction \>or =50%.
- Their Chest X-ray reported normal.
- Their Ear ,nose , thorax will be clinically evaluated by a specialized ENT physician to ensure fitting for hyperbaric chamber
- Voluntary acceptance of participation in the study . B)
- Participants will be excluded if they have :
- Chronic obstructive pulmonary disease.
- Cardiac pacemakers.
- Epileptic fits.
- Physically disable .
- Any disorder that lead to ulcers other than diabetes such as ahistory of chronic peripheral arterial disease. Exclusion Criteria: \-
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 55 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.